compared
achnoid
bacco
▁socioeconomic
▁fecal
26
▁alp
▁1.46
mortem
mined
odular
9).
tified
organism
rease
adder
CRP
ocytosis
▁IBS
▁antip
ussion
▁uteri
-79
▁defects
▁mucos
ochromatosis
inflammatory
▁600
tine
▁plateau
▁confine
oselective
▁73%
▁Gonad
osin
Rs
▁cisapride
menopausal
▁lipid
cyt
▁(20%).
uestionnaire
▁analgesia
▁corticosteroid
▁51%
800
ittac
▁1.47
▁azathioprine
89
▁arti
▁286
▁TC
1),
lyb
▁clus
▁clonidine
osid
▁breakthrough
▁132
▁(4.0
▁Few
ints
▁Fib
▁70%.
1).
▁referrals
▁multin
▁appendic
poor
pir
induced
▁hospitalized
▁lesion
▁dermat
▁Vitamin
▁atenolol
▁strokes
▁interpretations
47
otrop
▁methimazole
▁55%
▁vaccin
ometrial
mentation
aem
atitis
▁colposcopy
llate
▁rigorously
▁leukocytosis
eprazole
▁repres
▁incontinence
▁(20
▁Assess
▁fracture
▁mastoid
ecre
▁residual
▁30.4
mation
vicular
▁-7
amide
piratory
▁Neu
▁untrained
▁5.2
▁calf
▁circumference
▁EMA
molality
▁multic
fasting
aminases
▁344
omatosis
methyl
▁203
▁Dental
▁homogeneity
▁biphasic
amilton
taining
roxen
▁(82
▁benzodiazepine
▁(97%)
▁abnormally
oscop
IU
omain
ocortic
.7%
▁upd
-16
eak
▁achieves
▁Mayo
29
▁74%
▁92
▁28
10).
▁(0.5
▁preparations
▁lithium
▁0.01).
vedilol
▁retinal
those
otox
▁salbutamol
▁HSV
▁benign
Cer
▁emo
▁116
▁disturbances
▁bisoprolol
▁lymphadenopathy
▁quinolones
keletal
achn
▁Gluc
▁amplification
valvular
▁withdrawn
▁eryth
▁PPD
▁356
esti
▁1.75
▁menopausal
▁antic
▁injur
▁insufficiency
▁wk
▁ecz
olem
eric
indol
▁confinement
titis
tents
▁supr
▁diverged
▁0.5
ologic
▁furosemide
▁diabetic
▁tubercle
▁adi
▁(1),
lycemia
▁persists
▁(1)
▁undetermined
▁vaccinated
▁stent
aline
ectom
▁Stress
▁(69%)
oretic
▁hypoglycemic
▁colonoscopy
diabetic
▁metatarsal
ispanic
▁diets
▁exceptionally
▁pefloxacin
▁9-
wes
▁socio
1;
▁125
54
▁283
tory
▁25
tact
▁choline
▁71%
erad
▁rup
micro
▁implicated
▁vaginal
▁prescriptions
▁contraceptives
avir
▁categorized
anin
azepam
▁oxymetazoline
▁1.4%
lycer
▁Likewise
▁52
▁undetected
icin
▁agonists
▁Coronary
▁127
▁aspart
▁palsy
▁intrav
▁4.5
tative
▁whee
▁(92
▁46
▁0.10
▁triglyceride
/10
▁benzyl
▁diap
▁21.
▁chan
▁lipoprotein
omann
▁5.5
iol
▁sugars
▁consis
plast
▁1.38
▁Successful
▁mite
▁quantified
▁4-5
▁46%
▁adap
onidine
▁0.12
guing
▁kinases
ostatic
▁expres
▁duplex
▁anoxic
▁(15
▁nore
▁interacted
arying
▁superiority
▁oss
welling
SDS
▁streptococcus
enec
▁TI
pirone
▁exercising
▁splen
▁AFP
alsy
▁conduc
▁acetaminophen
formin
▁curettage
▁430
amphetamine
otential
ondyl
▁attemp
▁41%
▁reproductive
▁(8%)
▁nulliparous
▁trig
▁subcutaneous
uplex
▁urinary
▁(1.2
▁certainty
▁journals
idin
▁emulsion
▁verapamil
coag
▁antid
/12
▁0.05
▁dex
▁(0%
▁spanned
▁Rates
▁skinfold
▁interim
moking
7-
▁microscop
▁susceptibility
▁symp
▁inappropriate
▁conflicting
▁polysaccharide
▁41.5
▁internists
▁0.77
▁54%
▁1%.
▁hepatitis
▁NPH
▁Relative
▁1.4
▁2.5%
▁obesity
▁compares
adone
▁paroxys
▁hypoglycemia
▁Statistically
4.1
▁melanomas
▁chorio
aginal
▁ascertain
Ta
▁adulthood
▁5.6%
-2.5
▁exud
anate
determined
▁340
▁antecedent
▁physiological
▁curric
▁atelectasis
▁Identif
▁embol
▁0.00
▁radionuclide
▁verte
▁24,
▁diuretic
▁4.2%
▁(16%)
▁tuber
▁68,
erb
nisolone
timum
▁enlargement
arthritis
2]
ecutive
▁cef
▁Pn
clin
▁193
00
▁detrimental
▁ischemic
▁hyperlipidemia
▁posttreatment
▁(16%),
▁46,
▁(40%
▁acute
▁overestimated
▁PLP
▁diaz
10),
▁excretory
▁leukotriene
▁fluoroquin
itidine
▁90.
▁tran
▁(41%)
▁Calcium
▁mononucleosis
▁obese
reactive
▁hypotonic
▁21.2
▁seropositive
44,
amethoxazole
tiary
▁recordings
▁luteinizing
/18
▁premenopausal
ignant
▁malignancies
ervative
-0.0
atesticular
▁(3.8
▁accessibility
▁postnatally
orated
lob
▁duodenal
▁surgeons
▁Oste
enteritis
tives
▁maneu
ilep
▁anticoag
▁renders
▁273
idic
▁warts
omat
kic
piration
▁databases
▁vancomycin
▁(99
converting
6;
▁pigment
▁23
▁cremaster
▁Combin
▁Bac
Cu
-0.5
uled
▁Streptococcus
uccess
▁adrenal
▁congestion
uride
▁extracts
41
▁menses
▁Chlamyd
▁ulcer
lomethasone
▁(39
▁Subjects
▁50%
abies
-65
▁intranasal
▁-0.6
▁transverse
▁elective
▁aberrant
▁stimulants
atum
oacetic
▁150-
▁5%.
▁Ib
▁hypothe
uminum
▁posth
▁Stroke
▁0.1
osts
▁occult
ucas
▁cartil
tant
▁stenting
▁21
▁surgeries
▁SIDS
tically
hexidine
▁splenomegaly
▁Randomized
▁limbs
sustained
▁sulfonamide
▁Addition
▁217
entia
ignificant
▁6.6%
▁0.49
▁levamisole
▁(4
went
▁9,
▁DBP
▁4.8
-8.
▁39%
▁suicides
▁1985
▁overlapped
-1.9
esic
oride
▁uncontrolled
openia
onyl
▁(63%)
blockers
▁indo
▁ethnicity
▁247
ocin
▁Magnetic
3),
▁corp
sych
▁occlusive
▁sutures
ischemic
▁adenoid
▁erythromycin
▁CVD
-2.
▁lis
▁antimicrobial
▁undergo
rocy
opulation
sors
▁OA
▁kinase
▁refractory
▁protoc
hea
▁nominal
▁postoperative
▁assay
▁immunotherapy
sparing
▁multicenter
▁pell
endi
31,
economic
androgenic
▁Secretory
▁cosmetic
▁surrogate
▁duct
havi
ystag
▁1:
▁Afric
quisition
0.6
rected
▁reticulocyte
▁5.5,
▁enrollment
▁chlorthalidone
vice
ytes
▁aqueous
oneph
▁ejac
▁breaths
tency
roph
▁regulate
opa
▁systolic
▁(67
8)
▁numb
▁82%
EMG
39
▁Apgar
▁57%
ceptive
atally
▁MCV
▁carcin
▁(0
olates
ducing
▁alcoholics
▁gemfibrozil
▁Clinical
opamine
▁molecule
▁conception
▁(6
gol
herence
4),
scop
▁attenuating
▁(93
ococcal
▁neoplasia
▁96%,
plenic
▁(19
▁supplementation
12
▁suppor
▁pathology
ipients
18,
hered
▁Dys
▁elevation
▁550
▁macros
▁cereal
▁durations
dered
57
sants
▁1600
▁316
▁moderately
▁detec
ipril
0-
▁0.5%
▁viruses
alc
▁17.8
▁3/
raconazole
▁obstructions
▁supervised
▁vesicle
▁fertile
▁(80
terol
▁cancers
leukin
-18
▁102
▁Recommend
▁exposures
▁0.15
▁favors
▁postinjury
▁satisfactorily
▁instruc
▁Reas
000.
cinolone
3%
trop
▁suppression
▁analogue
▁1.1
rhea
▁biopsied
irubin
▁rheumatoid
▁osteoarthritis
▁2.5
▁headache
▁intest
▁estradiol
▁transluminal
▁balloon
1:
ficial
zard
bral
▁Included
▁7
▁outpatients
▁0.60
▁Conventional
▁traum
ocrin
6%
▁uniquely
▁enzymes
7/
▁perone
.00
vate
dine
▁83%
tizing
▁exacerbations
iasis
medicated
eclamp
odality
65
▁hypothesize
▁8-12
▁ocular
amus
▁betamethasone
mature
icine
▁penile
▁repro
tinent
▁31%
▁weakened
antoin
amid
▁91
▁endpoints
scher
▁urine
abdominal
▁suture
000)
▁discontinuing
▁unfractionated
icacy
▁clinics
iology
adders
▁PMS
127
▁enroll
▁Exc
▁7.7
geal
ventricular
▁BCG
▁maturity
▁6%
hydration
severe
administration
▁carbohydrates
roscopy
uebec
▁MM
▁medically
▁titration
ardias
84
▁dyspepsia
iminary
ionized
▁persist
olis
erated
147
otransferase
Tu
▁1.31
▁injected
chloride
▁airflow
▁correlate
▁231
▁Nutrition
5%,
▁transthoracic
▁49
50).
uric
▁aggression
▁inguinal
▁SPF
▁nonsmokers
olesterolemia
tivities
▁13%
▁IgA
quine
▁ECGs
▁proportions
Wo
sives
idone
adily
dominal
ognitive
jun
SMR
tomies
▁isch
roscopically
▁nonsteroidal
ofil
▁PTS
artum
▁suggestive
▁curet
▁acupuncture
▁randomized
vail
1/
▁112
▁OD
▁juvenile
▁8.
ocardial
-9
imodipine
▁lacks
indings
▁encomp
▁Diabetes
▁Therapy
erating
▁physicians
▁9.2
▁pyl
albuminuria
▁33
▁solitary
▁anxio
0,
▁Hyp
partic
▁sheath
coh
toc
visc
▁Ace
▁duoden
lamin
onam
▁0.56
▁objec
▁300
eces
gian
▁dietary
▁87%
▁paroxysmal
reatine
▁stimulus
▁167
▁aspec
anic
hort
itant
5),
▁8.5
▁fulminant
▁homocysteine
ressive
▁2.4%
00,
▁polysomn
▁reversible
aryn
▁alprazolam
▁SMR
▁fibrosis
significant
▁Calc
▁52%,
▁Concentrations
▁gyn
▁poin
▁eti
apid
▁kits
▁coagulation
▁bladder
▁MEDLINE
torchid
▁retin
76
▁specificity
▁postinjection
▁endobronchial
▁233
tipation
▁(32%)
▁218
▁modestly
▁transplant
ductive
creatinine
deficient
▁margins
olus
▁soy
▁anomalies
arrh
▁hypoth
▁oxygenation
▁21%
/34
verages
Ox
▁cerebral
▁reticul
▁insufficient
61
▁95
heat
▁ison
junction
ycin
▁Chlamydia
fatal
▁277
▁extrap
idation
▁thre
▁friction
▁induc
▁immun
▁bronchospasm
▁145
▁750
gestion
▁Eleven
4,
▁cefixime
ochemical
▁30%.
mur
▁venography
▁15.8
▁cyc
anazol
3-
▁ves
▁abscesses
▁anes
▁185
▁1.09
▁thrombosis
aminase
yloid
partum
-4.
▁squamous
▁polys
visual
ophren
eared
ferrin
▁spacer
▁idiopathic
copic
▁attain
▁18.
▁stres
▁patella
▁multivariate
▁subdural
portant
igaret
▁voluntary
choles
jac
▁40-
▁reser
neph
ysts
▁2.1
▁calor
casein
▁phon
hydro
▁Benz
omated
ophen
adian
:30
ioid
olum
0.2
terus
▁undergoing
▁12.
▁neon
▁endo
▁suscepti
reased
andard
pig
▁nystatin
▁flora
PGA
5;
82
▁HBs
▁Incidence
▁comple
5%).
gression
▁ejaculation
94
hyp
▁(2
▁EE
▁20
▁mann
HB
▁anaerobic
▁0.35
terase
▁arter
orec
▁29%
oscopy
pore
lash
erable
▁9.7
▁physiology
▁epidural
▁acros
▁nitrofur
▁infants
▁105
▁3.4
▁normotensive
▁islet
athiop
▁16.
▁serotoninergic
luc
4]
alan
osacral
▁colpos
▁subfractions
ariate
▁shor
%),
▁activator
▁preceding
urate
▁93%
▁(4.6
▁relapse
histamine
convulsive
odone
▁proving
▁tended
▁(4%)
▁tendons
ivary
200
27
-5.
▁resolving
queous
▁spinal
▁nip
▁ingu
8,
rati
▁(5.0
▁obstructive
▁VV
cus
▁neuroleptic
etal
clinical
▁examiners
▁eighth
▁yearly
▁pravastatin
▁histology
▁sulfon
▁protr
▁allyl
POA
▁(90%)
▁duc
▁encephal
▁shorten
▁ampicillin
▁56%
odia
▁1/
▁(4.8
.6%
▁graf
▁ultim
▁perc
▁formulations
lamy
umping
estrogen
-35
▁5.
isoxazole
▁diastolic
▁rhabdomyolysis
itamin
▁Scale
▁1.45
primarily
▁1000,
vely
▁artery
▁8.6%
▁270
▁derange
▁91%
adine
urin
▁85%
▁Tiss
▁GAD
▁120
pap
sufficient
▁sleepiness
▁jaund
epsia
▁1.58
odip
baseline
▁colorectal
▁hematoma
ilus
▁sero
▁3-
roxicam
▁neutropenia
idating
▁1986
▁61%
detection
▁400
▁Diagnostic
▁-10
lusion
▁dyslipid
▁268
▁desatur
thre
▁ascer
▁deleterious
▁42%
hig
▁128
otroph
▁arrhythm
▁examin
▁magnesium
▁inflamed
BH
▁fertility
havioral
▁ack
24)
▁Thi
nei
▁18
▁saturated
oreal
▁(56
1-1
▁spac
▁4%
aturated
oronary
tations
urrent
▁ethn
▁(75
▁refusal
▁injections
▁nonsignificant
▁hydrophilic
sar
▁0.72
ergy
ventil
▁echocardiogram
urgical
aturation
4).
bacter
▁deterior
selec
▁0.76
▁275
▁bac
itro
inamide
▁pollicis
TN
▁conditioning
▁monit
▁biopsies
enol
yclic
erving
▁1987
ipheral
11
cephalic
imens
▁specification
amet
atation
▁Duc
▁Fourteen
▁Escherichia
▁90-
▁Reduction
▁(3),
▁superf
▁latent
phal
enin
inase
▁168
ionine
▁(33%
.7
-1.8
arcin
▁Forty
gA
diagnosed
▁7.8
▁12.5%
▁antidepress
4;
erge
sectional
▁logistic
▁Adverse
▁278
▁mycoplasma
xime
▁bloc
idazole
▁algor
17,
▁carbohyd
▁immunocompetent
▁modif
▁inversion
▁uninter
udent
▁sensitizer
istal
pharyngeal
:1)
ept
▁Urine
▁colonic
▁4.8%
▁coenzyme
.9%)
▁47%
▁hu
▁prolongs
0.
▁absorbable
▁tach
▁CAP
▁1.8
▁exudates
▁investigations
atell
adication
▁intraven
NB
9.
▁bronchodil
thick
▁bip
▁hyperb
▁progn
azin
▁twofold
▁apne
-1.
▁Ear
▁hir
▁inser
duction
uncture
TG
▁sonography
▁183
▁Respiratory
tance
▁transcription
▁33.3%
▁alcoholic
▁menstrual
▁6.9%
▁synthesize
▁Routine
opharm
rhy
▁encompassing
▁cholest
▁0.98
▁hysterectomy
▁celiac
▁specificities
ritis
▁granul
geons
tir
othyroid
▁thrombo
▁crossover
▁stool
▁depres
roxic
▁viral
,6
▁psychomotor
cytosis
▁nif
adequ
▁48
owever
▁Effic
▁correlating
▁42
ixation
lobin
▁2.3%
▁tymp
▁inversely
▁thi
▁initiating
▁beha
▁dosing
▁scarring
▁Trial
ospasm
imeth
▁274
▁plasminogen
▁discontinuation
acycl
▁192
olesterolemic
▁thiaz
stress
▁0.11
▁Angiotensin
lobulin
▁bismuth
Ra
/9
▁danazol
▁amniotic
▁panc
5]
limb
-7.
▁ulcers
ithromycin
▁fluor
▁dilat
▁decarbox
▁defic
▁1991
▁augmenting
vivors
▁prophylaxis
uminal
0.9
obac
▁phototherapy
▁radiography
▁1960
▁cryptorchidism
▁AO
▁invasive
notic
ospor
conventional
▁3.
▁reac
tally
▁1.7%
▁8.8
33
▁opioid
▁drainage
▁acces
▁inges
▁Seventeen
radi
%).
▁psittac
▁5
▁20-
▁erythema
▁nutritive
embran
RCA
▁herb
HDL
▁positives
roxetine
▁basal
▁pooling
▁elevate
▁0.1%
ystolic
▁negatives
carotene
▁meningitis
▁2.3
▁2%.
▁steroids
vival
irds
▁hernias
▁chemotherapy
▁assesses
▁8.2
▁midw
ritten
▁Absolute
-14
resistant
▁remed
Ls
▁concurrently
▁placebo
▁(70
▁smear
▁paradox
▁0.90
▁COPD
opro
▁hereditary
▁(71%)
spar
▁(-0.
▁35%
▁seb
▁respec
▁9
potential
▁1%
organic
▁0.06
▁0.23
ositive
2%
▁poten
▁retardation
ohnson
▁bic
meter
positive
actin
▁cephalosporin
▁3.9
hydrox
▁50-
epine
uality
iton
DV
thoracic
zoster
qui
▁3.5
urgery
▁clinicians
▁positional
▁postprandial
▁phenotype
orrh
Hep
ulose
▁intran
tein
▁64%
hap
edle
assessed
▁unnecess
▁appendix
essional
chlor
xone
enoid
uran
acerb
▁luteal
▁LMW
atological
▁glomerul
▁dairy
▁bedtime
▁134
▁autosomal
▁meperidine
▁mobilization
▁practitioner
▁146
-0
itin
ults
Ts
dic
zyme
▁Screening
atadine
▁81
▁(42
eliac
▁candidiasis
▁measurable
otine
▁2.1%
▁Statistical
▁occurrence
DH
▁Sensitivity
15
▁0.07
ASA
otor
▁Mortality
▁pec
77
▁stimul
▁CAD
tection
▁67%
0,000
▁ruptures
odipine
adenomas
dose
tropine
▁276
▁Hear
▁14.8
▁dehydrated
▁Epidemiological
glycoprotein
adm
clic
▁paradoxical
ABL
▁(25%
6),
othal
▁414
▁tas
opathological
▁averaging
peptide
▁administered
▁tolerated
adol
▁Transi
▁metoprolol
phen
iplinary
▁sequentially
posable
▁200,
▁70
▁biopsy
▁0.91
▁1.24
entile
acids
▁hemorrhagic
thmias
▁membranes
uprofen
ovascular
▁CHD
benefit
-45
5%),
6%;
▁psycho
incidence
inopril
▁PEFR
▁modeled
▁conclusive
▁5.7
ctive
▁Eighty
16)
▁Factors
Cs
▁stepwise
tropin
▁170
lysis
romycin
vents
▁thiazide
▁suppres
▁valve
▁yielding
▁Insulin
▁colitis
▁gradi
▁coping
▁derangement
strain
▁299
▁manifested
▁transi
▁5.9%
8).
▁cytology
tec
▁cate
▁absorpti
ventilation
dihyd
▁dimethyl
▁0.18
▁(9%)
▁30-
▁maternal
▁reflex
▁staging
▁oxytocin
tel
▁introduc
▁paired
.5
▁scanning
▁superficially
threatening
▁sequelae
▁63%
osclerotic
▁matur
firmed
▁7.
▁syndromes
▁neuropathic
▁Gyn
▁hypers
ejection
astatin
▁172
▁criterion
ropathy
▁cachexia
dihydropyridine
ocrine
oretically
orectal
▁179
▁hypocalcemia
▁86
▁antipsychotic
▁suppos
asthmatic
▁fractions
▁nodules
▁endogenous
▁detecting
GH
▁microb
8%)
▁genitourinary
▁Injury
▁abor
▁specifying
▁(2%)
▁Hep
▁scl
▁5.2%
▁Serum
▁Survival
▁thyroiditis
▁derm
▁Localization
▁amput
▁pharmacokinetic
linded
▁predic
oling
MW
adin
▁naproxen
exy
duced
▁percentages
▁lifest
▁actin
▁thrombocyt
oprost
▁stripping
▁predisposition
abd
irub
▁720
-5)
fir
▁28%,
▁abstinence
▁209
▁ND
▁bronchodilator
▁prednisolone
sodium
▁aspartate
▁Epidemi
esium
▁pharmacologic
buride
ophor
2/
▁20.
▁carriers
wk
▁hyperlipid
▁miconazole
oporosis
▁restenosis
▁(8%
agic
▁tac
▁induce
▁Esophageal
fec
▁agglutination
iae
▁simult
▁osmotic
▁parac
▁uterine
▁aerobic
4/
itively
Hb
▁estimating
rotal
▁hypercalciuria
▁ofloxacin
etent
▁longitudinal
ocomial
▁660
▁questionnai
▁0.26
1.1
64
▁Finnish
vating
▁aerob
13.
▁(60%)
153
oracic
▁colonization
anad
4.
1-
LG
▁confounding
yel
▁15%
floxacin
▁Invent
▁Adequate
thmatic
emin
▁premature
▁(2.6
▁bipolar
controlled
imazole
tigo
▁superv
atient
▁4.9%
▁1.5-
tam
bronchial
▁sten
▁ingestion
onance
▁cohorts
▁(24%)
reasts
.4%
ocrom
▁(2),
500
▁sham
thirds
▁circulatory
▁RR
sian
8]
▁effic
▁interferon
▁splenectomy
▁pep
ectable
▁progest
▁intracranial
oyl
▁intermittent
9),
▁rehabilitation
▁vitamin
▁22)
▁fluoro
▁prenatal
rogenic
ymptomatic
otyp
▁reinforcement
▁eradicated
▁disclosed
umetanide
▁peaked
▁acad
-1.7
sue
▁standardization
▁intensive
▁1)
athioprine
ociated
▁intake
amn
▁235
▁mU
▁postin
fication
▁(22
▁atten
▁lumb
acil
▁0.34
oste
erant
▁pneumococcal
5%
▁aids
▁dextrose
▁5.4%
erate
▁intrapartum
stim
▁dus
▁1-
odop
▁thromboemb
▁orally
▁contex
ocated
▁infectious
bearing
itching
ographies
versal
▁differed
▁0.84
lyte
acti
▁Infection
▁parental
▁96%
ventive
▁bathing
oag
ressing
▁radiologists
-1.3
tense
▁neonatal
▁competence
▁encompass
▁enti
▁regurg
▁57
▁enterocolitis
lyc
▁nebulizer
asalazine
▁580
▁13,
ipar
acet
illus
asic
thrombotic
▁superficial
▁experim
▁(3%)
ller
▁fla
▁confirming
utaneous
▁muc
▁succes
▁96
▁myopathy
lodipine
▁1.9%
▁polyc
ovarian
▁bacteriuria
▁normo
▁discontinued
ensi
▁graft
▁hypertensive
feeding
▁(1).
▁rigor
▁4.1
tomy
▁allergy
▁heterosexual
▁326
▁pertussis
▁60
▁rheumatic
▁beclomethasone
▁teratogenicity
▁decub
▁0.4%
ococci
▁choles
▁supplemented
-60
▁concentrations
achial
006
ograms
19)
▁7%,
▁fulmin
▁subjective
ritin
▁Bacter
▁assays
afe
▁ventricular
▁reductions
▁1.53
▁dementia
▁unsuitable
6-
▁bup
▁1.04
87
▁surgically
▁goiter
troduction
▁unilateral
▁comprised
▁beverages
▁285
tent
▁incis
▁Depending
gic
▁cholesterol
▁agonist
▁(89%)
▁2.5,
siveness
rachial
arrhythmic
▁allergens
▁complication
▁exudation
30-
endix
▁TSH
▁17.7
osac
ocysteine
otent
▁cardioselective
▁thyroxine
▁reviewing
95%
▁Capsaicin
oratory
▁angina
▁19,
▁182
▁Elevated
troph
▁3)
iterranean
LISA
▁cyclo
placebo
erally
▁6
▁gynecological
▁24.7
9)
▁buspirone
▁pneumonia
▁Investig
▁2,
▁rickets
diagn
inergic
tic
partate
▁32
▁warfarin
uscular
ethylene
▁gonadotrop
.3.
/24
▁secretagogues
▁CFC
▁(3
SAID
yzed
▁Intensive
ods
▁ejection
▁-1
▁incid
▁6.2
▁bran
7).
▁HBsAg
tero
▁Eb
▁3000
▁malign
▁fallopian
▁2.7
▁influenz
▁excre
utin
▁nicotine
fortable
▁anteced
▁anesthetic
mostly
▁clamp
responders
70)
▁0.40
orenal
tig
▁recurrences
pectively
▁0.19
uretics
atified
50)
▁retard
▁unin
progestin
▁steroid
azep
▁elec
▁GE
▁DSM
acting
3]
20.
sA
▁nonsur
▁ADA
▁prophyl
omplete
▁Interestingly
ithelial
particularly
urine
▁definitive
▁26.5
▁pooled
▁anticholinergic
▁immunized
▁surgical
▁sti
▁GER
▁multim
ronate
▁phosph
▁neurop
▁0
▁sput
otre
▁antibiotic
▁neuropsych
▁doubled
▁outbreaks
▁cerv
▁ramipril
opecia
▁hairy
▁overestimate
aminop
▁assis
▁fum
▁37%
▁Thy
▁CN
▁5.7%
apanese
▁3.5,
▁(5%
▁parity
ovir
▁defec
▁traumatic
▁perin
reduced
▁saliv
▁carvedilol
aerobic
volving
othiaz
▁capillary
▁Milk
tained
▁(31
▁cerebrovascular
▁washout
▁Modified
otr
dor
▁1.56
▁nitrogen
▁disadvantage
▁cessation
▁preserving
ported
▁audiometry
▁thyroidectomy
▁discharge
1]
▁hematologic
▁0.64
▁specialty
▁119
▁Fifty
2).
▁Highly
▁increments
93
▁interventional
▁vertigo
▁reproducible
NIDDM
▁crom
▁distinguishing
0%,
▁stenosis
2.1
tisone
▁DV
otriene
▁acutely
▁contiguous
▁arose
oung
▁incom
▁flexor
ludes
▁mEq
▁10%
▁vitro
▁discom
ameter
▁UT
fine
posure
▁expectancy
ochrome
orpor
ocytes
▁cystic
.5.
thi
0),
▁biased
▁critically
mediately
amphen
▁miscar
rents
▁concurrent
▁Swed
examination
hips
▁methyl
ometers
erver
omized
enzyme
▁produc
lys
▁Neurop
urred
italopram
▁15-
trin
oxin
75
▁incomplete
onary
▁(4.3
▁sonographic
▁pediatric
▁0.67
▁Bec
▁polym
lact
echan
Gs
olytic
▁293
▁indomethacin
▁84
versely
ocl
cence
eclamptic
contrast
vian
agin
ereb
rein
▁clindamycin
▁1.0
▁screened
rologic
▁adop
▁Maximum
▁16%,
▁continuation
▁hygiene
▁ambulation
responding
zymes
▁neonates
▁scre
Ca
irone
▁hyperbil
▁39,
▁Inventory
▁Severe
▁17-
▁23,
urea
▁51
▁abnormal
▁UTI
atisfaction
▁alanine
▁pylori
illary
▁27,
▁ranitidine
▁differing
esophageal
▁1.11
▁concomitant
▁enzyme
▁117
14)
eryth
-1.4
▁ESR
▁lability
▁139
▁6.5%
▁7.6
▁carbonate
▁emphasized
▁-12
▁underst
▁enlarge
▁intram
▁(1.6
-2.0
▁(7.4
▁pate
onvul
oxetine
▁hyperactivity
▁90%,
sant
affec
▁4.0%
▁persisted
ectomies
▁detrusor
▁denser
▁(0.9
▁evacuation
enters
atrial
▁eradic
▁recurred
iuria
Ig
▁1.07
umerous
▁20%,
amisole
titution
▁gland
5).
tors
▁amphetamine
razolam
▁hypercal
waves
retin
▁Alzheimer
onegative
oglob
LH
reported
itus
cessive
▁obstetrical
epam
vitamin
▁phosphate
▁inh
▁5)
vus
▁musculoskeletal
▁awak
▁retic
▁1.15
opramide
onazole
▁lact
▁8.4
orrhea
rometry
▁sedim
▁101
▁pharmacists
▁159
▁causal
▁pharmacokine
tivity
trophy
-85%
VH
▁diuretics
-3.5
▁bowel
▁tricyclic
pirin
anking
▁78
▁Examin
▁positively
▁randomization
▁gum
▁fluids
/30
▁perit
▁Hb
▁wee
▁serologically
mia
▁spasm
▁86%
▁103
odopa
▁saphen
▁67
▁26
▁147
▁doubling
▁114
ogenic
onate
ticular
▁wheezing
▁genital
▁successive
▁carc
▁17
6.
▁plas
▁Surgery
ylene
▁nadir
▁atopic
▁systemic
ergency
finding
adal
gressive
▁interestingly
onates
▁extracorporeal
▁buc
5/
▁amoxicillin
▁couns
▁kidne
▁1000
▁persisting
.2%
▁9.
coated
▁40%
glycer
▁varicella
▁amputation
ulitis
▁advan
▁pulmonary
▁FDA
▁4.7%
jec
▁5.0
▁1.2,
▁psychophysical
▁decreased
MH
▁uncomplicated
▁exer
▁psychotherapy
oprim
armac
▁deviations
▁manifestations
▁impairment
▁concludes
10
▁tetrac
▁0.026
▁optimum
▁insertion
▁admissions
▁neurolep
▁worsened
AFP
▁simplified
▁adipos
▁Dip
▁lem
algia
▁50,000
▁264
tep
restricted
27.
▁diagnose
▁5.3
▁79
▁Disorders
▁7.7%
▁capsules
▁arthroscopy
▁neoplasm
▁disturbing
aceous
biased
▁indus
osteroids
▁Doppler
▁nonm
▁outlet
▁47
▁routinely
▁Reduc
63
▁doses
cretion
▁5.5%
NIH
lood
isolated
encephal
▁sugges
▁androgen
disc
▁diagnoses
▁satis
▁215
▁adversely
▁0.82
▁dysrhythmias
▁bicarbonate
▁exploratory
15.
▁accid
eeding
▁70%
▁peritoneal
▁100
▁0.17
▁spas
▁venti
▁ipr
▁prostatic
ospitals
▁nonp
terin
▁3%
▁(21
▁-5
ectomy
▁6.1
▁stools
tinu
inol
▁ambul
.1,
▁amin
hydrop
▁electr
▁confers
▁variously
oprolol
-81
▁lorazepam
▁Tissue
▁0.7,
▁hazards
endazole
infection
▁55-
▁psychosis
▁physici
ocarcinoma
▁prolactin
▁perce
▁methodology
haled
adic
▁10%.
▁cytologic
▁22%,
▁loos
▁attenu
sistent
▁8
▁hexa
▁clarithromycin
▁0.13
organisms
▁lumbar
biotic
tum
▁efficacious
▁onset
▁exacerbate
▁regimens
▁topical
23
▁tremor
▁abd
ternational
▁88
▁classify
▁tuberculosis
▁HL
▁sickness
▁3.8%
▁inadequ
▁142
▁expressing
▁(5.3
▁antibody
5%)
▁hypogonad
▁transferrin
▁biochemical
▁promp
▁avail
ostomy
idney
▁1.35
▁0.45
▁receptor
blood
onomic
vular
▁hydrox
▁60-
▁22
▁propionate
▁neurologic
▁66%
▁immunobl
▁therapies
udin
-100%
▁135
lated
0%),
rays
▁4;
tral
entif
▁dosages
▁subgroup
▁Higher
▁IU
orbent
▁ankle
.10
▁2.4
▁irregularities
▁abnormality
140
▁undere
▁infarctions
▁31,
inatal
▁flexed
rowing
ecretory
leuk
▁preeclampsia
ecu
▁Thir
▁CIN
▁tol
▁pretreatment
centered
▁therapeutic
▁PEF
ethyl
▁analges
▁compartment
▁diagnos
▁malarial
▁sulbactam
▁lymphocyt
oten
▁77%,
deriv
▁16
▁nifedipine
natal
-600
▁43
upus
▁hazard
caro
▁erosion
▁Biopsies
antial
▁ovulation
.9
tured
25,
▁63%,
charged
▁Phen
▁CRP
▁insulin
▁colic
▁56,
▁epidemiologic
109
▁discriminate
tical
▁cran
lep
▁mening
-1)
ylated
▁decreas
atriptan
▁Americ
▁3.7
▁reinfection
▁electrolyte
▁93
▁normalization
▁0.016
▁Aspirin
▁levonorgestrel
istor
▁methotrexate
▁ionized
▁(1%
▁inherent
daily
▁imaging
▁(14
▁Somatic
▁Assessment
▁Increas
Au
▁56%,
disciplinary
▁Optimal
▁suprac
▁uncom
▁appropriately
▁intub
nec
▁asymptomatic
▁arrhythmias
▁1969
▁radiological
fractions
opo
▁6.9
oppler
▁causation
▁angiotensin
ungal
anat
▁prostatitis
▁stratif
▁fasting
▁examinations
▁50,
▁237
5)
cine
obronchial
ocaine
▁preventive
atical
▁factorial
▁inconsistent
▁graded
▁49,
▁intractable
usively
▁mortality
lec
▁voiding
▁7.9
▁precur
▁augmentation
▁0.09
▁Initi
▁1.95
tiguous
▁damaging
-96
▁bronchodilators
▁excessively
▁rupture
meg
▁(89
▁mononucle
▁judged
▁150
▁(10%),
iscal
▁tiss
▁(85%)
▁underway
/6
1%
▁Multiple
tise
▁manu
NH
ratic
COP
▁hormone
▁atopy
110
▁bromocriptine
▁pelvic
▁mitral
lod
▁spikes
▁confound
naud
▁15,
early
▁interventions
▁Copenhagen
▁anemia
▁dissemin
▁polymy
-22
▁1.18
▁11%
▁unrecognized
▁simultaneous
929
gment
emia
imaging
▁(250
-1
▁dysfunction
▁-0.4
▁cardiac
stin
meth
▁regained
▁insomnia
operative
▁106
drug
▁(1.0
opril
reasing
10-
▁1.12
▁45
▁111
▁perfusion
▁foc
8),
▁(16
▁CDC
fal
pine
▁fractures
▁Mast
ocyst
inj
ystatin
nisone
8/
▁physi
▁Comparison
▁recipients
productive
▁(5.1
▁titr
cents
▁stimulant
▁7.5
uitable
sus
▁irrigation
▁pren
▁maneuvers
▁0.81
▁AGA
▁universally
▁relapses
▁lifelong
promoting
▁conductance
embry
▁occl
▁abnormalities
83
▁26%
▁recor
LDL
operatively
▁Reflex
▁Combination
▁disturbance
▁hypokal
oxic
▁-0.0
ystic
uria
▁cylinder
opre
nai
▁33%
▁relieve
▁merit
▁rhinitis
▁hypokalemia
-10
▁scans
▁inhaler
▁datab
teroid
ocys
▁revised
ominant
▁endemic
▁97
▁succinyl
▁50%,
enil
odiazepine
cB
ovastatin
romy
3-4
sively
▁clon
▁nicot
omyces
▁80,
trogen
▁(500
ticle
iparous
administered
▁(75%)
▁neph
▁atrophy
▁statistic
olig
▁antigen
onor
ustained
injury
▁15%.
xual
▁predominant
▁menstruation
cale
▁nondis
tran
▁0.2
-5
▁24)
▁avoidance
xin
▁nig
▁perinatal
▁bladders
lowering
▁secrete
▁behavioral
▁relaxants
gents
▁dehiscence
vertent
ducible
▁MMS
otonic
▁serolog
▁abscess
etirizine
▁CAL
▁expiratory
▁121
▁(49
▁4.
cyclic
▁clu
▁122
▁outflow
▁detects
osmolar
-]
▁rhy
▁30
plasty
atural
▁hypertro
rophilic
▁microbi
▁80%,
▁recurrent
quid
▁endeav
▁PID
icul
anese
horm
▁173
weighted
▁condensed
▁5000
▁acetyl
▁threefold
tive
3%)
▁methodologic
tensin
▁suction
▁posi
opathy
achol
▁androgenic
▁intravenous
▁20)
HF
▁limb
▁0.2,
▁physiotherapy
▁unreliable
13
▁glucose
-25
▁selec
▁equivalents
▁41
BMI
▁200,000
ections
▁Seventy
linic
ophil
orac
pregn
erebral
stem
▁BMI
▁inhal
00)
▁constipation
astine
▁adjusting
nosis
▁250
▁0.7
▁lumen
▁Levels
▁grains
gluc
66
▁cyclospor
▁ae
▁0.88
▁genotype
▁slowing
▁methionine
▁transient
pecially
▁benefited
othi
ulants
▁1983
▁resol
entical
▁1.17
▁(78%)
▁Neuro
▁fetal
▁hypoventilation
▁33-
▁morbidity
21
▁clues
▁nonc
ranolol
▁antifungal
▁aspirin
oxid
retest
▁440
▁sensitivities
▁glucocorticoids
▁19.
vity
▁(84
▁glycosylated
(6
yx
onin
▁0.86
tif
▁Asi
▁uric
▁reiter
▁0.05%
▁gastro
▁lymph
▁154
elic
▁2000
▁enteric
0.8
▁emerg
VAS
▁persis
Ep
▁newborns
▁herni
▁5-
▁rati
▁proton
▁sple
acr
ayed
EDL
▁(95
▁(79
▁321
▁1.13
▁7.5%
.7.
amines
▁500,
▁fibrillation
▁anesthesia
romal
erop
▁underestimated
▁fatty
▁underg
▁0.42
▁examining
▁undiagnosed
▁0.93
IgM
▁rGH
arental
zine
▁adiposity
▁80-
▁prolonged
OH
▁summarized
inic
▁intrauterine
reactivity
arynx
10)
▁dips
arre
▁dorsal
▁16.1
▁verbal
crip
▁eczema
muscle
arial
erin
▁0%
-8,
▁antihist
▁suicidal
▁sulfonylurea
▁pharyng
▁36
olamine
▁cranial
emetic
▁mildly
▁Outcome
▁births
avail
PPP
oskeletal
▁pollic
tics
50
▁creatinine
▁11.5
toxic
▁ligation
venous
tested
▁clot
▁252
aryng
00-
▁esophageal
▁stu
▁carbonic
calorie
▁methodologies
raine
kely
amel
▁perioperative
▁Framingham
owel
▁clinically
spectrum
▁remin
3).
▁thromboses
▁worsen
eptin
▁Haem
▁234
▁exudative
ulcer
▁hypercalcemia
9/
▁MRF
lovir
-4
▁prednisone
8-
23.
iplin
▁esterase
▁MDI
▁ana
▁anomal
02
▁308
tential
▁desaturation
▁chorionic
▁68
▁fathers
monary
▁commercially
▁synovial
▁internally
▁25%.
arean
▁diarrh
▁22%
▁retested
▁latex
olerant
▁colos
▁1.01
▁fric
.8.
epti
spectively
▁0.80
strual
olpidem
lline
coronary
▁endos
▁16%
▁0.01
▁cyclical
albumin
elec
▁206
tention
icep
▁4.7
acted
tene
PaO
▁0.8%
uracy
▁mono
▁radiographic
▁sebaceous
▁prognostic
salt
ffer
▁PEG
▁nasal
▁4.3
▁nonin
▁40
bran
flammatory
teric
450
▁ulc
▁heavier
▁addic
▁esophag
▁enrolled
25).
▁3.0
luding
▁(68%)
oluble
▁memb
▁(44
▁cytoch
athyroid
deficiency
iability
phine
▁Failure
▁Lact
ofl
quamous
98
fetoprotein
▁302
▁bilateral
▁37
▁atypical
angiotensin
lun
56
▁albuterol
ucle
▁4.6
▁163
▁82
▁adolescent
▁eradication
okine
Gy
▁abl
▁-0.5
▁amp
▁10.0
osamine
▁PCR
▁adip
▁(10%
▁regimen
▁1.3-
▁spirometry
parative
▁PPV
▁NN
0.4
▁Whereas
▁thrombus
▁LD
teroids
▁bism
▁262
timulus
prac
▁8.0
ytoin
usually
▁subf
utive
▁8.1
itrate
ocusing
▁reversing
▁0.38
▁comprising
-1.6
oplasty
▁Viral
▁irrig
▁acqui
tension
tigu
.1%
ilol
300
▁(26
▁inadequately
▁strengthening
▁Abdominal
omycin
▁antim
releasing
▁(1
▁171
inally
▁titrated
▁incidence
▁iat
etus
▁cramp
▁potenti
vaccination
▁82%,
▁unil
▁infec
▁qualit
▁(20%
▁phle
▁comparisons
▁Beta
▁endocrine
▁MIC
brile
▁8-
▁Hyd
▁vesicles
▁angio
▁Lactobacillus
▁multiv
▁retinopathy
▁vomiting
▁anemic
▁133
▁desm
▁(94
0.00
iodine
.8%
▁discontinu
▁10.7
trates
▁Caucasians
▁Suc
reases
▁attrib
▁Abnormalities
▁elevating
▁xylitol
▁endoscopic
ocytopenia
▁antich
▁vertebral
containing
▁untreated
▁Fram
▁(97
▁Smoking
▁2.
arous
▁1.6-
-2.2
▁epidemi
▁4-
▁adverse
▁familial
▁lipophilic
hydr
meterol
cis
18)
-3.0
initi
▁cellul
▁operative
▁reactivity
conver
ulant
▁antichol
trimester
gli
▁thyroid
9%
sess
▁triazolam
tate
▁mellitus
▁outpatient
olesterol
▁Prac
ureas
▁perforation
▁insol
▁resul
stab
cad
▁controver
VV
▁165
▁CABG
▁fibr
▁Extr
▁(72
▁fulf
▁arteriosus
protein
▁bleed
Nor
▁exag
▁1.48
thma
▁generalized
▁streptococci
▁stratified
izability
thromycin
vices
▁(36%)
▁erg
.1
▁palp
▁(15%)
▁antibiotics
venty
▁lactobacilli
7%)
▁trimester
▁intrap
tte
gthen
▁ascorbic
▁impairs
▁disseminated
▁primiparous
▁labial
▁412
jected
▁(35%
median
▁bacterial
azone
otropin
illi
▁noncom
anine
▁morphine
▁conges
▁emergent
▁unres
▁sulf
▁acyclovir
cutaneous
▁1.3
▁phleb
▁antec
▁contamin
▁airway
▁endoc
▁granulomas
▁serological
atab
▁therapists
ymmetric
▁(95%
ibrate
edocromil
olam
turb
▁lidocaine
7;
▁responsive
▁cyclooxygenase
▁deli
onatal
omatic
hormonal
fraction
▁1.36
▁streptococcal
▁sumatriptan
▁Secondary
▁granuloma
▁confounders
▁unipolar
ervical
38
▁triglycer
▁Evaluation
▁chlamydia
▁linearly
▁antithrombotic
stimulating
trast
▁(67%)
▁27%,
▁interf
oxine
-2).
▁3).
isters
mental
▁theoretically
▁Evidence
▁1.29
.0,
ervations
▁unchanged
▁mec
▁0.8
:3
unctional
▁inflamm
▁255
▁statistically
62
romes
imentation
ocor
iagn
▁subscapular
cture
echanical
▁whey
▁indefinite
mented
▁nylon
▁transmitted
▁77%
▁Ventricular
traction
▁64
▁compartments
▁resour
▁etiologies
ohns
▁serogroup
▁meticulous
ureus
-34
ergic
▁prognosis
▁vegetable
ucl
versity
embers
▁demonstrates
opam
▁sprin
▁affec
▁8%
▁identifiable
▁escalating
▁-0.7
▁urography
▁25.3
fied
▁stric
▁(0.0
ococcus
▁jeop
53
ffective
▁(90%
▁suppressive
(1
▁11.6
▁Longer
thmia
▁acet
▁80
▁exacerb
▁chloramphenicol
▁drin
hyd
▁0.6%
▁shortened
▁metatar
merc
▁sulfonyl
yridine
ulsive
rosemide
▁reflux
lication
▁proximal
▁6.4
32,
triglycer
▁efficacy
(7
smoking
▁arthritis
trophin
produc
ardized
▁4.6%
▁challen
retroviral
tions
▁49%
▁relap
ionic
▁-0.8
▁malignant
▁discomfort
▁0.30
▁triam
▁shedding
▁quantif
▁LVH
aind
▁resear
▁189
ophilus
▁1500
▁48%
▁cured
▁revascular
▁1.00
▁previ
struc
ectin
▁ester
▁amn
▁ultrasound
▁Consequently
▁200-
▁concordance
▁mmol
▁quin
tivation
▁carotid
▁155
▁renovascular
igarette
iotics
▁14%
▁85
▁excretion
years
angl
▁ach
▁(2.5
thood
chol
cysteine
▁quoti
yocardial
103
▁1.26
▁Preliminary
14
▁requi
onography
eck
▁investigator
19
▁aluminum
▁oxy
▁(58%)
(3
orphine
▁Factor
▁assessments
▁EG
▁acidic
79
▁323
▁14.5
▁3
▁plasmin
rox
▁acnes
surgical
▁80.
agonist
▁hypogonadism
▁propensity
▁pentoxifylline
▁serology
dens
▁propranolol
▁surgeon
tion
▁plasm
▁6.3
▁corticosteroids
▁Sodium
▁biases
▁grise
▁empirically
▁(63
▁28)
▁lor
cellent
▁osteoporotic
▁resis
▁Acet
▁oxym
▁deviation
10,
cervical
▁Treatment
▁corpuscular
▁criter
uppressed
▁construc
▁nasopharynx
parous
botic
▁glycol
▁prophylactic
▁0.70
etence
▁Enal
▁systematically
▁Prevention
▁practiced
14).
xide
▁deoxy
▁nonspecific
▁antibodies
osite
ymp
▁supple
▁87
luded
▁retur
olones
▁cephalosporins
▁neutroph
▁gout
▁60.
▁drip
▁prostaglandin
18
▁557
kage
▁retention
▁1.2
azolam
ifedipine
rosy
icillin
athic
▁4)
itone
▁pla
▁pyr
▁INH
▁neomycin
▁Thirteen
▁1.08
.6
erum
genic
kelihood
▁lymphocytosis
ocyte
▁Clinic
▁(62%)
81
rotein
pecific
▁effec
▁6%,
chool
▁pellets
▁Estimates
▁107
▁unexpectedly
ensitivity
▁glyc
ritical
robial
▁ventilation
▁tolerability
therapeutic
greater
▁Notably
72
▁infarction
▁Delayed
gestational
▁testosterone
▁excluding
▁rats
uted
▁Doses
▁impair
▁saphenous
hydroxyp
▁severity
▁Depression
0.3
▁mcg
▁cesarean
tilage
60
▁Ninety
retion
▁rash
▁anticoagulation
▁0.5).
▁etretin
▁attendant
▁1,
▁tubes
▁casein
(2
▁Comparative
atent
▁etretinate
▁lowering
▁Estim
effec
ronchial
ruc
▁1.25
▁gly
sul
▁urinalysis
▁5%
▁1.02
▁intramuscular
ADA
gestrel
heavy
9-
▁1.4-
anol
▁prevalence
arrhy
▁Caucasian
▁ribs
-50%
▁carcinomas
etoprotein
▁0.89
▁strains
▁Adh
omagnes
▁Behavioral
▁infrequent
▁daytime
▁Subsequent
▁Individuals
uin
chid
▁predictor
2,000
fibrozil
▁cefaclor
1-4
▁257
▁90
▁hep
▁tomography
25
oconazole
ermal
trac
▁regression
oglobulin
▁resuscitated
ipolar
▁suppressed
ustion
absorption
▁Enalapril
oidal
tox
▁antacids
▁appraisal
▁ovarian
ionate
▁EST
▁attenuation
▁clinician
▁analgesic
▁infections
▁initiation
lip
▁cann
▁pectin
▁40,000
▁euth
▁deliveries
▁Regarding
▁26.7
blind
▁impaired
titut
▁exis
▁postmortem
.6,
▁144
97
▁localized
▁weighted
vements
▁1.16
tite
enal
hers
4-
▁oint
▁BV
nish
▁isoniazid
CABG
valine
▁chec
oxicillin
onephritis
▁bouts
▁scalp
▁malformations
sions
▁Oral
bic
▁methodological
▁dizziness
injection
▁1.6%
weigh
▁Patient
phil
-52
ographically
uble
30,
▁Progesterone
▁embry
▁sut
omegaly
▁24%,
▁8%,
▁uter
▁felodipine
▁hepat
▁blot
233
▁oximetry
▁0.08
▁prevalences
▁retrospectively
inoc
3/
▁Prevalence
▁(150
ofib
▁4.0
▁BMD
▁mIU
50),
osage
orating
▁0.50
▁gluten
▁Leu
terl
pretation
amphenicol
omal
▁renin
▁chloride
▁40,
epin
▁injec
▁identi
▁herp
sequent
PCR
▁221
▁Engl
hetamine
otamine
cious
▁35-
▁(1/
▁euthyroid
hene
vasive
oretical
▁fluconazole
▁markers
▁CHF
▁polymyxin
▁3.1
▁surrog
▁2.0
tage
▁predicting
▁heavi
lox
▁Institutes
▁0%,
ective
entricular
▁2)
▁Approximately
enicillin
arachnoid
▁hygi
▁glucocorticoid
amethasone
▁anticonvulsants
▁(12.5
chlorothiazide
▁assessing
▁10.8
erence
▁deoxyrib
▁131
ilization
▁carbam
▁solit
▁136
▁70-
▁antidepressants
odies
▁20,000
roth
▁50
rance
▁CU
▁30%
▁supra
▁ventilator
rans
quit
▁EI
▁vulgaris
▁TMP
▁lep
AO
▁spontaneous
▁chlamydial
▁comparative
▁tenderness
▁medicines
▁inad
ocar
▁hepatocellular
ture
▁84%
▁econ
▁Hg
olism
▁spre
▁itching
▁trimethoprim
▁0.87
▁162
▁antidepressant
omiting
▁(1.3
▁Breast
insulin
▁83%,
▁cardiovascular
smokers
amole
onad
▁12.0
mittent
▁8.4%
▁CAH
▁lactation
▁genotypes
25)
erose
umbered
▁implants
▁200
▁rhabdomy
▁0.36
▁albuminuria
▁contractions
certain
36
alian
▁iatrogenic
-800
roma
▁studi
▁dyspnea
increased
▁calorie
▁favorably
opharmac
rography
▁Leuk
▁skeletal
▁intermedi
ralfate
usate
▁137
ampl
▁urtic
▁amph
▁positioning
▁186
▁cen
▁Nons
ipramine
▁Transient
▁10.
▁fec
▁sputum
occurring
▁titers
▁obstruc
▁256
uretic
▁psychiatric
opar
2.
▁perfor
▁Lymph
80)
▁secretagog
▁VAS
▁89
▁donors
▁valu
▁48-
oil
40.
tually
lytic
▁gon
▁lith
itudinal
▁(50
▁appra
-36
▁coordination
omerular
▁computerized
▁metab
▁elimin
▁0.22
▁OC
irc
▁secreted
▁inadvertent
▁caries
20).
▁menstr
chl
cellular
▁hydrolys
▁bronch
▁2
▁TS
▁19
▁590
▁39%,
oxazol
▁proteinuria
BMD
▁79%
lamyd
▁hyperplasia
▁vaccination
▁adolescence
▁antioxid
▁substitution
▁Fewer
▁metastatic
▁hepatotoxicity
2,
▁thirds
▁20.5
170
▁deem
▁25,
▁targeting
▁10.2
▁pressures
▁subjec
ulting
▁qualitative
▁12%,
cros
▁adjus
TCA
▁synthesized
▁196
▁0.74
▁bacteri
▁characteris
blinded
▁zinc
▁Alz
1)
▁halved
ichia
▁metr
▁Ure
7]
1.2
calor
▁allele
▁prospective
▁1.5
▁cartilage
tronic
▁cytochrome
▁syncope
▁13.2
▁(40
▁89%
▁4
▁Candida
▁1.44
▁bacteremia
▁stratification
ophilic
ffin
▁Excluding
▁meningococcal
2.2
▁abduc
▁pem
▁mammography
▁1.33
esity
▁(69
trum
▁leuk
▁hemat
cycline
▁psor
▁nonprotein
▁(28%)
▁spi
▁249
otom
▁quartile
inemia
fat
▁hemorrhage
oglobin
sia
thickness
▁HPV
▁depressive
▁28.
▁abr
iological
▁nonsurgical
60)
prising
▁3.6
diagnosis
▁compositions
ituit
▁aden
tration
▁restric
▁hypertension
dial
▁reas
▁anxiolytic
▁resection
▁constellation
respectively
lyce
intestinal
essation
▁budesonide
▁Retrospective
▁polycystic
idate
▁brevis
▁exhibited
▁vasoconstric
▁900
sion
▁fetus
▁schedules
▁topically
aturity
▁118
glucosidase
▁hypnotic
▁(10
▁reproduc
▁multimodal
stro
▁calcitonin
▁ureter
▁crosso
/0.
▁115
ometh
leu
▁keto
▁LN
▁confir
afloxacin
Ba
22,
utions
▁0.79
omagn
ipine
adrenergic
▁esters
ifed
▁snoring
▁30%,
edding
▁Diets
▁compart
▁symptomatic
▁brom
▁(24
6)
fiber
ystitis
▁concom
▁7-
▁269
▁calcification
▁overt
trib
april
37
-72
▁amenorrhea
▁postpartum
▁noninvasive
▁Exercise
allium
ymal
▁carcinoma
▁3.2
▁6.6
▁halves
▁thir
▁90%
odil
▁Gynec
▁discriminant
▁preterm
duce
adren
excluding
▁urticaria
propanol
▁lavage
▁cic
▁5.1
▁(100
▁angiogram
▁tib
▁muscul
ardia
▁(400
tus
▁delirium
nons
▁fossa
▁acne
▁triamcinolone
▁fluc
▁(7%)
0).
regulation
amol
▁HDL
yste
▁Adding
igl
▁pleural
▁quotient
50.
initiated
amilies
▁0.62
▁CST
▁lateral
uppression
▁beats
▁presentations
ypass
▁provid
▁symptomatology
▁hydroly
▁hydrop
▁multis
amycin
▁congenital
▁resistant
▁juven
▁quantit
distal
▁headaches
▁tetracycline
▁hypothalamic
tib
▁deox
▁toxicity
cyte
phosph
umption
▁excised
oprotein
▁-0.3
▁0.27
▁potent
ortic
▁34
▁cardio
▁simvastatin
▁pulmon
49
▁progesterone
▁schiz
olac
thalidone
▁pneumoniae
▁incub
▁pregnancies
▁evaluating
▁fas
▁yielded
onucle
▁tric
▁1986.
▁pharyngitis
▁17.3
▁800
▁Cutaneous
14.
▁(84%)
▁(43
osteroid
▁obstetric
▁98
▁averaged
▁2/
▁Histologic
▁decubitus
▁intrac
asal
actam
▁digoxin
▁HB
Ti
▁aerosolized
▁consecu
▁sequenced
▁interp
▁scro
▁glycos
opus
esin
specified
▁benzodiazepines
atients
ordination
lactam
isole
▁filtration
▁glomerular
▁pH
▁inten
▁autoantibody
tensives
faction
▁pati
galy
ovaginal
astases
▁NP
FEV
▁292
rals
▁241
▁hyperglycemia
acterial
ipr
▁menopause
lactams
▁instrumented
▁bilirubin
▁vagin
2-
▁postnatal
▁prescrib
▁morbid
estim
mild
yrid
tering
ulence
▁85%.
▁hemorrh
ected
▁lessened
▁allergenic
hicle
▁TCA
▁proges
articular
acute
weeks
atoid
▁Medicare
▁Symptom
acid
▁parathyroid
▁Specifically
▁ultras
12-
▁exceeded
roscop
▁anhydrase
anide
tation
▁transvaginal
▁choleste
▁Chronic
▁ticlopidine
▁Significantly
▁(80%
atology
dil
aturia
▁(140
rement
▁appendicitis
▁substanti
mL
▁calculi
▁62
▁renal
apsulated
▁85%,
arate
▁Antibiotic
▁(6),
▁ciprofloxacin
▁164
identified
▁penicillin
effectiveness
▁metastases
ogonad
blocker
▁hypos
ochem
▁-0.
ymptom
▁laparoscopy
▁autoantibodies
▁balancing
▁optimally
▁ketoacid
▁weakly
▁immunoglobulin
3-2
2),
▁inhibitor
▁unresponsive
▁practic
99
▁codeine
▁compli
▁(1000
lyl
▁58%
arrest
upuncture
▁296
formerly
▁Antim
▁80%
obacillus
▁reactive
▁psoriasis
▁mucosa
zinc
▁75
▁81%
reening
▁hyperthyroidism
▁(76%)
▁uncl
20
▁Fifteen
▁indeterminate
-6
osterone
edema
-70%
onorgestrel
emide
▁teratogenic
idem
cemia
responsive
▁repor
▁premenstrual
▁303
▁metformin
▁elicits
▁74
regn
▁spirometric
▁69
▁semen
▁ultrason
-20%
parathyroid
▁placenta
▁NSAIDs
▁DVT
ostic
▁IUD
▁uro
▁implying
▁14%,
▁metic
yrox
▁ferrous
▁(27
▁65%
▁recom
ophyll
25.
enteric
▁psychopathology
lym
ogenous
▁pulses
90).
esia
▁nitro
▁(1.5
sibly
▁quintile
▁heterozygous
inesterase
▁scientif
▁-2
ecal
▁alb
▁serotonergic
400
▁gels
▁electromy
▁hypocal
▁Risk
▁prodrug
▁alleviate
▁100%.
▁neuropathy
rosis
▁ASC
▁respir
onine
tingu
▁evaluations
▁antagonists
7.
ocalization
ontal
obic
otoxicity
ogel
▁selective
▁rifampin
▁104
▁cryp
▁27%
▁Replacement
urban
▁11.2
▁paren
▁395
▁contaminated
44
▁(0.4
ventional
▁1.10
Ni
▁7%
▁expec
tyl
▁endocrin
.4
▁predominantly
▁congestive
▁157
5.
olated
▁Hib
▁78%
osyn
▁diffus
▁0.75,
▁arrhythmic
▁elastic
FSH
adequate
▁endoscop
▁223
90,
lies
4%)
▁paternal
4-2
▁incision
▁199
▁chol
▁mitig
▁HS
cyst
▁cephal
immune
ithi
▁52%
▁predis
eration
▁CI
azol
arbonate
usp
▁0.3%
mend
▁129
sac
ilic
▁PGA
▁evol
▁11,
▁gestational
▁hos
▁Impair
ignific
▁hepatomegaly
▁75%
▁adequ
▁favoring
▁clamping
aminophen
▁polyethylene
▁nef
phin
ampicillin
▁distorted
▁Myocardial
Ly
▁243
▁11
▁Cooperative
▁0.97
▁perip
▁distal
▁17.1
"-
▁55
▁exce
▁-3
▁Feeding
hemolytic
▁Cumulative
▁33%,
mokers
-10.
▁scars
▁187
▁35
▁bioavailability
ximal
oconstric
▁micros
▁hetero
tist
4%
▁mep
8%
6%)
▁10.4
perature
▁parat
Pa
oderm
▁regurgitation
avoid
.2
▁DF
▁jaundice
▁bradycardia
▁prematurity
▁2.2
▁Lipid
tenti
▁220
▁4.9
▁Meas
accharide
▁exhaus
▁13-
▁immunogenic
isal
▁coughing
▁individualized
▁proceeded
▁1.05
▁roughage
▁infusion
▁carbohydrate
52
▁spon
▁LM
▁bony
▁76%
▁correlated
▁remission
availability
.8
▁colectomy
▁microorganisms
▁343
kine
▁speculation
molar
opausal
▁lar
tomized
▁4.4
▁uncovered
▁cholesteatoma
▁Raynaud
▁morb
▁bronchoscopy
▁plaster
otherap
17
▁Computed
▁20%.
▁endoscopically
ailure
▁lessen
▁oils
▁poorer
▁MH
▁22.
▁direc
enon
osal
▁adipocytes
▁pea
▁0.59
▁sodium
prandial
indolol
eptide
▁24
▁58
▁(45%)
▁Ultras
otassium
vic
vul
ausea
▁0.6
▁-15
▁10.5
isol
▁affinities
▁anticonvulsant
idis
▁valerate
▁ineffective
▁ulnar
▁10-
▁caregivers
▁bactere
▁(9
/1000
▁4).
valent
▁enrol
imin
▁infancy
▁Antic
3.
dip
/3
▁tes
▁0.29
induc
▁subc
▁heterogeneity
otoxic
appropriate
▁nonresponders
ositi
▁subclinical
tens
▁transfusion
exin
.3
▁0.14
▁1.03
lamp
▁(=
otrexate
opal
▁0.25
▁1.19
aund
▁(21%
ipit
▁Epidemiologic
inum
▁Centers
▁marketed
▁EB
▁deform
▁allergic
▁100,
▁MRI
spective
▁thresholds
ogens
immun
▁reti
zation
▁Increasing
seud
5,
gia
▁somatic
gth
▁nodule
▁Hypertension
gesia
▁parox
▁oste
▁7.2%
izin
▁PV
ogenicity
▁mell
▁0.55
▁poses
▁leukotri
▁irritable
▁infarct
yrib
▁edema
▁ketoconazole
▁latency
▁yeast
▁100,000
▁Indo
▁optimizing
▁investigators
coun
▁Newly
▁pharmac
▁postoperatively
CAH
▁20,
▁0.94
▁thromboembolism
▁antepartum
▁hydrochloride
ulon
Pu
▁electroly
▁descriptive
▁(2%
parathyroidism
odine
ocomp
▁88%
▁microorganism
▁multiparous
porting
7)
▁ointment
elan
▁unex
edic
▁hypot
▁ecological
▁blinded
▁PCO
-80
▁0.5-
▁pts
▁1.06
esting
▁0.66
measured
lora
-1.2
alp
throm
predominant
▁Ps
ertion
▁12-
▁lumbosacral
apine
oic
▁orch
▁monotherapy
▁ceftriaxone
▁nonsmoking
ROS
▁Bronch
▁-4
▁microscopic
opathology
▁lute
▁12%
effects
▁persistently
roin
▁hairs
▁swab
▁1.30
▁diarrhea
▁omeprazole
onc
▁ACI
▁0.33
▁76
▁variability
titudes
▁72
▁cetirizine
apamil
WBC
carbohydrate
tioned
▁orthoped
▁detectable
21.
▁1.9
▁59%
▁underwent
▁61
etine
34
▁immunosorbent
▁enlarged
hiscence
▁43%
▁brainstem
▁adnex
▁(38
32
▁endometrium
▁ablation
▁antagonist
phosphonates
.9%
pressing
▁horiz
cholesterol
▁bypass
-90%
hion
imination
olol
▁(77%)
astatic
▁somn
▁chor
▁aureus
molec
▁1990
▁tibia
▁carp
repres
2)
ropath
cepti
▁throm
assi
▁imipramine
▁WHO
▁relaxant
orin
▁metronidazole
▁intracerebral
lactating
pH
ulatory
▁pneumon
▁100%
▁Subsequently
73
idespread
ropion
thmic
▁ket
▁(46
▁(18%)
▁adequately
chers
irubinemia
▁glycoprotein
▁cardi
▁alginate
▁recruited
▁67%,
▁1.6
▁embolus
▁backgrounds
-4.5
estions
▁modifying
▁dox
opharynx
uris
genital
▁asymp
otri
tro
▁dissection
gesterone
▁electrom
▁Tric
7),
ortal
heum
▁neutrophil
▁(25%)
itonin
ediatric
▁sensitiz
2;
▁immunity
▁torsion
▁350
▁bumetanide
phosphon
▁melanoma
gus
bility
imethyl
▁gonadotroph
▁Increases
▁bronchial
aggressive
▁(62
22
▁enalapril
▁intolerance
cortisone
▁apnea
▁indications
▁focal
▁Diagn
▁asthma
▁ruptured
▁44
▁lymphocytes
iatric
▁77
omial
▁relieving
▁nonoperative
▁3.5%
▁hypop
/100
12.
▁effusion
▁Sulf
quired
▁thromboembolic
50/
▁349
▁6%)
onit
2%)
iclovir
▁pancreatic
▁presumed
▁HLA
▁xyl
0%)
0.5
▁estrogenic
classified
▁captopril
promazine
▁incontin
numbered
▁309
▁(17
arbox
erican
jects
▁phenyl
▁treadmill
▁necrotizing
ogr
sies
▁38%
-3.
▁2.9
specifically
▁6.8%
48
▁mefloquine
▁hydrocortisone
▁inhibitors
▁consul
ticularly
▁concep
utable
aric
▁92%
▁vigorous
▁definite
▁antenatal
iphene
▁crust
▁cystitis
▁problematic
▁antihistamines
▁functionally
▁aneurysms
▁lax
▁inadequate
0%).
dia
▁reliability
▁6.7%
ypro
▁encephalopathy
sulf
ylase
estive
▁sedative
▁Pertussis
▁metabolic
▁veins
▁Wound
▁intercourse
roscopic
phor
1.0
▁212
▁nonres
▁deposition
▁fungus
urrence
▁cutaneous
mol
risk
▁Combined
95
▁formulation
▁enamel
moderate
▁miti
▁citrate
▁osm
ecia
▁aspiration
▁progestin
releas
ithin
▁adhering
▁hypoxic
▁vitamins
odiaz
▁(12
▁gonorrhea
▁25%
adjusted
▁amlodipine
▁ductus
▁68%
▁histamine
rof
▁63
▁masked
▁Improved
ocellular
▁poisoning
▁ascorb
▁HbA
▁slows
vated
▁pyraz
▁0.03
▁epidemiological
titute
▁caffeine
▁ranged
▁0.3
▁erythrocyte
▁Pneum
.3%
▁pretreated
▁Mild
erent
▁respiratory
▁obstruction
opause
▁Estrogen
▁coated
/90
▁metabolism
sibility
▁wors
▁inpatients
58
▁blu
roids
▁cyst
▁95%.
ucose
▁constituted
valence
▁gastric
tide
proved
▁ELISA
ordin
alities
▁(18%
alic
130
▁(88%)
ylic
tosis
▁(0.
butamol
▁unvaccinated
5-
▁Patients
▁ank
▁commerc
▁longus
▁99%
▁pretest
▁lactulose
▁validated
▁brisk
▁Findings
concentration
tia
▁irregular
hemo
▁38
0.1
▁traction
▁15.
▁nephropathy
▁induction
▁manipulation
enyl
▁regain
▁tonsillar
leural
▁uv
▁induration
▁(2)
▁0.28
ysm
ergen
8;
▁hered
enan
▁nebul
▁counseling
▁TDI
yroid
crib
▁extensor
▁statis
▁65
vertebral
till
▁histologic
▁43,
▁158
▁migraine
1.5
▁excision
▁98%
▁proce
,000
▁fluoxetine
▁glucosamine
illin
▁TM
rength
▁gynec
▁Disease
▁occurrences
lipid
▁smears
▁estrogen
farction
tility
▁adhered
osclerosis
-50
3,
ritish
orsal
▁serotypes
▁0.25%
directed
lamydia
▁nondi
invasive
▁312
▁abbreviated
iline
▁fenoterol
▁53
▁18.3
▁endoscopy
erance
▁predictors
nowled
▁enteral
ophag
▁gases
▁disposable
▁characterizes
▁diazepam
osporin
pregnant
▁2.9%
▁227
▁Hispanic
▁increas
cancer
-23
5%.
▁preoperative
continu
▁establ
▁benzoyl
▁attributable
▁inver
▁extrac
▁blocker
6,
okinetic
▁280
▁adenopathy
▁endometrial
▁converting
econd
▁lapa
▁abbrevi
▁anhydr
▁struc
onset
-100
▁noc
ociation
opi
elong
▁Tran
▁fibrill
▁FD
▁adver
▁tympan
romatosis
▁32%
85
ipid
lavicular
▁itraconazole
▁soluble
▁inconclusive
▁syphilis
120
▁DMP
▁amo
▁Myc
bac
EI
▁(300
omia
mum
▁97%
▁333
▁11.0
eded
trial
▁expulsion
▁acquiring
gative
peri
vaginal
▁239
▁hemo
▁occupational
▁kidney
itoring
▁hypothal
▁28%
afibrate
▁0.5,
cobalamin
▁efficac
▁transaminase
16
8.
▁pim
▁comorbid
:1
▁diagnosing
elvic
▁160
▁insom
▁Prel
associated
▁ECG
▁44%
▁Sixty
ectasis
▁6-
▁atropine
▁650
▁29
quam
▁ect
-2
opr
▁kidneys
▁5,
roxy
▁(32
▁trac
▁glycemic
▁cereb
referred
▁aro
▁(30
▁(75%
ixime
▁precursors
▁1.42
drome
▁1
▁perox
▁14,
▁Ig
tric
▁deficit
▁(1%)
▁microbiologic
OA
)],
melan
▁47%,
▁evaluates
brom
umulative
▁decayed
▁sediment
umbers
▁0.61
▁Efficacy
otypes
▁electrodes
▁tablets
thromb
▁hematuria
▁hypothetical
exercise
ophila
▁uncommon
▁lutein
eptic
▁0.7%
viral
▁Measure
▁epilepsy
/4
▁Positive
▁terat
▁490
▁ure
aryl
etaz
▁300-
▁heterogene
▁prox
▁108
temperature
tissue
▁4.5%
▁fati
▁0.95
▁regularity
▁dilatation
icides
ycardia
iazide
▁SPL
thyl
motic
▁favored
lux
▁sucralfate
▁placental
▁nutritional
▁heel
▁vascular
96
▁Twelve
▁Staphylococcus
odal
▁testicular
▁1.7
▁bronchitis
titutes
▁unrelated
▁contracep
▁myc
▁inducing
▁cis
ffec
teral
▁lowers
▁antisecretory
facturing
▁65%,
ognition
▁modalities
bumin
▁experimentally
▁iden
-1.1
resist
admill
▁29,
ycline
ighted
kets
-2.1
cation
50,
▁standardized
▁minus
▁erythematosus
▁7,
ximum
▁3;
ronch
▁simplex
▁genit
▁enox
▁radiograph
jective
.0%
▁0.0
▁gonad
▁adhesive
▁Carotid
▁searches
▁alternating
▁grading
▁42,
▁18%.
▁cerebro
▁9.5
▁exaggerated
▁Formal
▁minimally
echn
▁7.2,
atible
▁absorptiometry
▁LT
▁stringent
▁hemochromatosis
▁prospectively
▁niacin
olitis
▁0.99
▁(5%)
▁infrequently
▁7.2
inyl
opian
olone
▁(0.6
tening
▁modality
▁hypertrophy
▁fibros
gestin
▁uterus
▁differe
gated
▁arterial
▁40.
▁21,
▁pituitary
▁fatigue
▁Nineteen
▁TIA
▁antioxidants
▁abstin
▁inflammatory
▁tendon
▁Arter
▁ery
▁unbiased
▁0.44
▁0.2%
IgA
▁cultured
▁progression
atoma
vaccinated
relaxation
illar
epines
▁2.7%
74
▁(1.25
▁discus
▁13
▁1966
tch
urys
▁17.
▁Hispanics
▁Systolic
aryngeal
▁gonorrh
reast
59
▁prednis
uterine
ulla
ritic
▁100-
▁0.69
1-2
-8
▁developmental
▁ovaries
▁immunization
tional
LR
iotensin
▁levodopa
▁Combinations
900
▁transaminases
▁precordial
▁elevated
▁ventil
nine
▁serologic
veness
▁tibial
▁birthweight
▁venous
▁minocycline
acial
atectomy
overall
athy
idated
▁alopecia
loxacin
▁adolescents
▁identif
▁30.
leb
5);
▁adenomas
▁norfloxacin
▁(4-
gesic
rocyte
essive
▁contraceptive
erative
andida
ophy
▁hepatic
▁palpable
▁Physicians
▁0.54
▁arrhythmia
▁moth
tituted
tis
-0.
▁tamoxifen
▁eliminating
▁compounds
olon
▁0.52
▁0.9%
motor
pecial
▁glutamic
ergenic
▁helical
▁singleton
▁69%
▁2.5-
▁influenza
ocycline
▁progestogen
▁dosage
▁54
▁atrial
600
ocardi
24
jury
▁53%
gely
▁(25
▁infusions
▁canc
ithium
coagul
▁complications
tially
▁febrile
▁Improvement
▁covariates
▁(28
▁(5
▁RA
▁immunos
▁placent
estis
68
▁ABR
HN
thin
retic
/2
▁esophagus
▁12,
xyl
▁glyburide
▁tolerate
ffe
▁artifact
▁receptors
azole
▁Premature
▁metered
92
▁substances
▁triceps
▁Injection
CHD
sensitivity
4)
▁preexisting
▁promin
din
Ds
scopy
tiz
LN
▁methadone
-1).
▁281
▁thereafter
dL
▁misoprostol
▁8.5,
oxifen
▁0.83
trical
▁cyt
letion
BV
▁(4)
▁ech
renal
▁salivary
▁Steroid
(0.
▁1.32
▁questionnaires
▁waking
rates
▁symptom
rele
otting
acquired
▁IgG
▁histological
▁azithromycin
sible
rine
▁progressed
hospital
standardized
▁antipsych
monitoring
▁0.21
plementation
▁bacitracin
menstrual
predic
(5
▁immunoblot
▁(33
▁blin
▁deformities
antibodies
atif
molecular
-40%
30)
▁fixation
▁endotracheal
needle
tussis
▁sorb
▁coronary
▁hemorrhages
bly
vaccin
adenoma
6).
rane
▁tertiary
▁1991.
▁cortisone
▁adren
▁sexually
orbid
-1.0
▁enl
▁dehyd
▁etiology
▁Infants
▁cys
▁Hyper
▁Caps
7,
▁trichloroacetic
▁ligament
▁229
▁45%
▁pharmacy
▁estrogens
loro
▁13.9
anis
.5%
enic
▁unco
▁probes
▁rectal
15).
etan
ypical
tur
▁chlorpromazine
▁glands
▁femoral
gm
▁piroxicam
plemented
▁relied
▁benzo
retro
▁predictive
▁(60%
▁72%
▁(98%)
verbal
tition
Lac
▁unusually
▁acetonide
▁antagon
▁RSA
▁197
▁4.0,
▁capsaicin
▁weighed
▁Prospective
▁95%
▁amitriptyline
▁otitis
90)
11.
▁Functional
▁neurotrans
▁Urea
▁1964
trover
urther
ophysical
▁asthmatic
▁melan
▁myocardial
▁succin
▁infertility
Hg
pli
▁favorable
osition
opathic
▁Increased
pran
specificity
▁anatomic
700
▁pulsed
NSAID
onas
▁caro
9%)
-78
▁cac
35)
HbA
▁hepatotoxic
▁atherosclerotic
mortality
▁abdominal
yclo
▁neurogenic
0%;
▁analgesics
-66
▁anticoagulant
▁90%.
loid
12).
▁diphen
plants
▁deterioration
ophys
▁anat
iters
umented
IH
cessively
Fs
▁competent
scherichia
ubs
▁arth
0%
uating
▁3%.
01
hydropyridine
▁stimulation
▁glucocortic
▁5.4
▁cavity
▁1.
▁seroton
aldosterone
▁10
ordance
ffinities
lax
▁ambulatory
▁hypon
▁(86%)
▁infar
▁14.
▁gentamicin
▁2.6%
opped
▁311
▁11-
▁Fluc
cemic
▁spleens
occal
▁hypog
▁subgroups
▁2%
40)
100
▁gonadotropin
tures
▁allergen
▁irritant
▁dors
▁HER
antibody
▁Caucas
▁delaying
▁Combining
idase
ameters
sied
▁premise
dle
▁sedation
feron
,000)
acrine
24,
tism
▁glycosyl
▁195
▁sulfoxide
55
▁RS
▁surveyed
▁malaise
▁differenti
orotic
▁Systematic
▁leukocyte
▁trich
▁correspondingly
▁sinusitis
▁dor
ongest
rogesterone
▁classifications
▁156
vascular
3)
▁argues
oxygen
▁provoke
vation
▁covari
▁0.41
▁smokers
erus
-3
▁44-
ctomy
bodies
▁malabsorption
osyl
▁2.8%
12),
▁25-
▁resonance
▁diclofenac
roxyprogesterone
lac
iteal
▁swit
▁triad
tracted
oplasia
▁Holter
▁defib
▁3.6%
▁24-
ometri
▁necro
▁(7.2
ughter
▁athlete
▁0.04
▁sci
▁cep
▁inhibit
▁clind
tionally
pharmac
psych
▁caregi
▁0.51
▁dentures
omethacin
neonatal
amicin
▁130
sored
▁Stro
-7
cystic
.0
▁Veterans
▁psittaci
▁IB
-6,
▁24.3
▁endometri
▁ppm
▁responsiveness
xate
▁cysts
▁flunarizine
Gi
ranean
▁angi
▁pyrid
chond
odic
▁LMWH
▁hyperthyroid
ducts
▁thrombotic
▁alcoh
▁perim
▁referral
▁Neph
9,
▁Thoracic
▁angiography
▁Lyme
▁disabling
dosing
▁(5.8
oprol
▁creatine
▁conservatively
roat
▁elic
▁articular
▁12.5
▁(72%)
▁ketoacidosis
▁3,
35
▁techniqu
▁14-
▁interleukin
omotor
tinguish
▁nec
gag
▁rehabil
▁questionnaire
average
▁cumulative
lometh
▁1.5%
0.7
fusion
▁dopamine
5-0.
▁Testing
eclampsia
▁dextro
atropium
▁isolates
▁3.3
▁infertile
ofen
▁Topical
neumon
▁59
▁treatable
▁invasiveness
▁hyponatremia
▁orthostatic
▁lisinopril
fib
▁incompletely
▁echocardi
resis
▁Haemophilus
▁cervical
▁musc
▁absorp
▁(3)
vit
1%)
46
olp
▁Significant
▁adenocarcinoma
▁offspring
91
▁4.3%
▁(31%)
▁(50%)
ranial
▁0.65
mega
15)
322
▁iso
reness
▁hypothyroidism
romised
51
TSH
omies
14,
▁lupus
▁(76
▁validity
▁Geor
▁7%)
▁Comparing
▁quadrup
▁atyp
ameth
▁ori
▁7.1
▁autoimmune
▁inflammation
▁94%
▁cohort
oconstriction
▁caloric
▁supplements
▁(1.9
▁pyridoxine
▁inspiratory
0)
▁dihyd
aemic
gement
▁60%
ration
olysis
▁Subjec
▁nonf
▁3.8
▁confirmatory
▁preven
▁zoster
▁unpredictable
lier
osus
avage
▁2.6
▁Laser
▁abdomen
▁regulating
▁9%
▁3.7%
▁termination
80
▁compressive
▁seroconverted
intensity
tively
▁dysp
opram
▁tuberc
▁Adherence
▁diabe
▁insignificant
▁8.6
ditional
▁exten
olerance
▁malignancy
▁smo
consuming
▁intestinal
ispanics
▁17,
▁0.1,
ilateral
▁cros
timulation
ureth
▁13.3
▁tracts
▁Parents
▁gluc
▁42)
▁mice
116
▁arous
dent
oxyrib
timate
▁228
▁capsule
iotic
eal
hydramine
▁Recurrent
obl
▁10%,
▁percentile
▁asymmetric
▁monitored
sulfamethoxazole
▁4000
▁194
▁gonococcal
6/
astric
onide
tiveness
▁LDL
▁serum
▁carpal
▁tox
▁(8
▁clomiphene
▁readings
▁observational
ochrom
vac
▁arousal
▁coag
▁tubercul
▁MCI
olec
oscopic
▁aggre
▁satur
▁hypotension
▁indi
either
▁differen
7,000
40
▁reversed
▁62%
odon
▁pneum
69
150
▁dehydration
▁Surgical
▁hyperg
▁elemental
ayers
▁glomerulopathy
▁-9
▁adherence
▁Compared
▁benz
▁clom
EG
▁(15%
▁puncture
adox
▁(23
establ
▁60%.
▁grouped
▁ibuprofen
▁aerosol
▁fumarate
▁attainment
ALT
▁(1:
▁defecation
▁Specificity
asses
▁overweight
▁sulfate
▁exhaustion
▁17).
▁protec
▁unstable
▁chewing
uting
▁drinkers
/20
▁ow
▁usefulness
rk
expressed
10.
assium
▁0.63
▁ovulated
▁11.8
▁osteoporosis
bladder
oxazole
azoline
▁bivariate
epithelial
▁neutralizing
▁acetate
▁decarboxylase
trated
teroidal
▁undergone
7%
▁Decreases
▁94
▁restraint
▁nevi
30
▁identically
opres
,3
lives
▁herpes
▁unaffected
▁Biopsy
▁95%,
aternal
-20
▁80%.
▁Nit
▁meniscal
▁0.4
▁urodynamic
▁insoluble
tural
▁auditory
earance
▁dermal
formations
86
exposed
▁sampled
▁Thin
ormone
▁nonrandomized
▁ICU
▁adul
dg
▁emboli
▁aided
WB
▁rotavirus
0%.
▁therapeu
▁rigorous
tious
opsy
▁demonstrating
▁HAM
ithm
anding
PV
▁electrolytes
corrected
rofen
▁110
patients
▁progres
▁Ade
-13
azepine
▁39
omyc
/32
▁postural
▁doxazosin
▁uniformly
▁6,
▁Epid
hydrated
88
▁-6
tebral
omn
oprostol
enia
42
LU
▁hyperch
▁Changing
loride
▁leu
▁700
▁ane
▁66
▁(47
DNA
▁exhibiting
asone
▁tic
traumatic
▁peri
elves
▁elevations
▁70.
▁qualitatively
▁retrospective
▁TP
▁peripheral
uestion
idne
▁uni
▁guinea
vastatin
acetic
▁stripe
▁(50%
▁12
▁angioplasty
iatic
▁1.21
▁plaques
▁Surve
uling
oligo
▁splenic
▁illnesses
▁practitioners
▁ratios
▁tet
▁embolism
▁36%
▁18,
▁8.3%
▁visualization
▁99
▁abortive
▁5.6
▁9.9
▁(10.
▁transformations
Ace
▁hypox
▁classifying
▁obser
▁0.02
▁solids
▁23%
▁nontoxic
▁LR
▁preschool
▁unwanted
▁sampl
▁murmur
onstric
▁205
▁ultr
▁15
▁56
myocardial
▁membran
▁elas
centr
unar
▁intra
-1.5
▁Bacterial
▁Thyroid
▁equivocal
▁0.2-
gulation
▁sting
▁bolus
ziness
LV
▁6.2%
▁uptake
▁0.
race
agonists
▁quinine
▁nonselective
▁unselected
flamm
▁3.2%
istar
-6.
▁microvascular
▁postmenopausal
▁rhe
/8
hepatitis
openhagen
▁SG
orbidity
▁demonstrable
nee
acin
▁recurrence
▁antis
▁nitroglycerin
ffeine
▁Acad
▁incompetence
▁1.40
▁sedimentation
▁spor
▁triglycerides
predominantly
▁Chang
▁181
▁nondiabetic
▁sclerotherapy
▁schizophrenia
positives
ACA
▁Melan
▁thems
attern
▁contrib
▁obstetr
▁(3.0
▁initiate
▁communic
▁gestation
▁omega
▁pancreatitis
SBP
▁nonex
▁16,
▁congen
timal
tice
▁1.2%
▁equi
▁263
▁151
▁imaged
▁sati
▁folate
LTS
meas
▁lacked
▁tendencies
-125
-2)
▁cromoglycate
phetamine
▁lesions
-1000
▁immunogenicity
▁hypo
▁75-
apular
.0)
ovis
entral
▁Progression
iloride
▁10,000
oplasm
ygen
78
▁decreasing
ophageal
▁valpro
▁PCOS
▁nonpro
▁188
▁antif
▁dye
▁208
▁chemically
ancomycin
▁naf
entified
▁RAS
▁mL
▁reflec
▁109
▁8.3
▁6.
▁accounted
▁Nine
▁gastroenteritis
xiety
▁inducer
▁quanti
▁cortisol
▁pathologic
▁flashes
▁nipple
▁(11
taz
/7
▁ipratropium
▁instrum
,2
▁esophagitis
▁diffic
▁glut
▁(45
▁ultrasonography
1);
▁198
0.0
▁prescribed
▁24.
▁weighing
▁subarachnoid
▁hydrolysate
▁theore
▁biop
potassium
itriptyline
uresis
71
tensity
▁cla
▁pathophysiology
oxide
▁123
ilin
▁0.9
tisol
emory
▁5.8
▁conjunctivitis
▁influenzae
▁Abnormal
▁140
respective
▁fasci
▁possi
acteria
▁261
▁amiloride
▁blister
▁unrel
alazine
plas
bronch
examin
▁valproic
▁1200
fate
43
▁warr
▁stren
lop
▁albumin
ovirus
▁empir
▁intraepithelial
▁deficiency
reas
▁withdrew
Hyp
▁propor
▁CG
▁retinoids
▁valproate
▁2.8
▁psychosocial
▁rheum
▁discharged
-15
105
-17
-400
▁113
atrop
▁baths
uates
urement
▁hyperp
▁sensi
28
▁promptly
▁immunocomp
▁glycer
▁83
▁dexamethasone
imus
-88
viron
▁receptive
/1
▁diminished
▁chorion
ealand
plasia
yro
▁cuff
pation
▁Tolerance
▁potassium
▁0.71
generation
▁markedly
oxyl
▁0.20
▁terfenadine
▁75%,
▁saturation
▁scrotal
▁chl
phic
▁opioids
▁1.2-
within
▁radiologic
▁incomp
▁(49%)
dural
0/
razole
▁quinacrine
▁Cardiovascular
▁rhin
enem
▁frac
▁fluoride
▁rebound
oterol
izine
tolerated
▁279
umably
▁(18
conduc
▁divertic
▁150,
weekly
osm
▁Complications
thyroid
ourinary
▁86%,
▁carbamazepine
▁acids
▁blockers
1.
▁resec
▁1989
▁reliably
▁enhances
▁(70%
▁2-
odds
-90
death
▁percutaneous
▁unrestricted
▁0.48
▁prescribing
▁5%,
31
atosis
▁18%,
▁prol
traum
aminated
amuscular
▁0.43
3.1
tial
▁toge
▁acetic
▁inhaled
-12
▁metast
▁facet
▁166
▁6.5
▁worsening
▁LV
▁3.4%
▁exclusion
rowth
▁Rif
▁nocturnal
▁correlates
▁34%
▁plantar
▁152
astolic
dition
estion
▁unexplained
-19
▁improves
▁leakage
▁cholinesterase
▁Rout
▁Sixteen
(4
▁32%,
▁adjustments
▁analyses
▁osteopenia
▁testis
▁seronegative
▁assessed
obenz
▁0.46
tensive
▁psoriatic
urnal
scheduled
triglycerid
▁doxycycline
▁1970
▁polyp
xia
hypertensive
70
cys
▁evid
ifferen
▁posed
▁confirms
▁enal
▁audi
▁fetuses
▁cutoff
▁37.5
oagulation
▁differentiate
terone
▁inhibitory
▁plotting
pain
Bs
▁fulfilled
▁tumor
▁coli
▁284
▁subsets
▁contraception
cribed
▁wards
sive
▁gradual
alb
▁4.2
21)
▁interc
plen
apride
tron
▁antiarrhythmic
yroxine
erythro
▁Subcutaneous
▁summ
▁antimic
9]
▁calcium
▁eccentric
▁Atrial
▁27
feren
▁differentiated
9;
▁contraction
ingers
▁19%
▁arteri
▁recr
tiv
▁ischemia
▁tumors
▁40%,
▁glomer
yses
▁cortic
▁177
▁Subjective
hep
▁metoclopramide
▁chronically
-2.4
▁hydrogen
▁neutrop
▁0.58
oporotic
▁17%
▁dipyridamole
▁dihydro
trol
▁devi
▁paral
▁feather
▁endarterectomy
▁73
▁tec
▁anomaly
▁STI
▁0.57
teria
▁marginally
difference
▁interfer
▁(48
▁dias
▁cyclosporine
surgery
ews
▁sorbitol
oxif
dihydrop
▁accep
acental
dop
▁352
▁297
▁31
▁cotinine
▁560
▁unclear
udation
Cy
▁HI
▁coh
ipro
▁lovastatin
▁71
vant
▁Trials
▁(54
osomal
orption
▁nonpregnant
individual
▁discon
▁nonfatal
▁NSAID
inear
▁unscheduled
19.
▁remo
▁11.
▁reflecting
▁14
▁Diabetic
3;
atches
▁nedocromil
▁substantially
▁40%.
▁extre
▁(1.4
▁dermatitis
osocial
▁milder
▁0.24
▁124
45
▁Infant
▁protracted
ocyt
-24
tices
gestation
aicin
▁hirsutism
▁adjustment
▁calcified
▁1.66
▁246
▁chlor
▁urethritis
▁dysplasia
buterol
▁DCA
▁agon
000
▁FEV
▁Sexual
▁swabs
▁213
▁Older
▁sepsis
▁quantitative
▁9.0
odium
farin
ths
▁endocervical
▁histopath
755
▁hypothyroid
vein
▁nasopharyngeal
▁176
67
▁hemoglobin
▁ceph
▁thromb
▁peroxide
pecies
mmol
▁methyldopa
▁rhinovirus
▁315
androgen
treated
▁Pregn
▁nausea
ostom
▁24%
▁empiric
▁Examination
▁emesis
orrhage
orrheic
athered
osom
orh
▁IgM
▁heparin
convul
topril
▁lipids
▁indicators
▁reduc
▁newborn
▁0.78
ogl
▁murmurs
▁chlorhexidine
alene
▁(7
-70
▁hospitalization
▁urea
▁cardiomegaly
▁bir
▁95%)
▁fung
90
▁conjunction
1,
▁Extensive
confirmed
▁1980
▁gonadotrophin
▁0.47
▁10,
▁pancre
enterolog
▁infrared
lude
▁IVC
▁vein
▁MRSA
▁phos
▁PSA
▁5.8%
▁decreases
ordial
CDC
▁allevi
idine
▁cephalexin
tual
▁20%
osol
▁combin
▁Registry
▁elimination
▁295
▁pyel
treatment
▁irritation
▁singlet
proven
▁ferritin
▁Intr
glycerin
▁126
▁Leukotriene
bA
▁erythro
▁13.
umbar
▁AMA
▁500
▁junction
▁Barrett
▁cruc
▁nosocomial
▁prostatectomy
acchar
▁18%
tin
▁contradictory
▁47,
▁0.75
ughters
comitant
ditions
▁Thirty
